Teradyne signaled confidence in the chip industry by committing $300 million to a strategic partnership with FormFactor. The capital injection, aimed at advancing semiconductor testing technologies, pushed FormFactor shares up 3.6% to $134.90. The collaboration highlights ongoing efforts to refine high-end manufacturing processes.
In section Market Quotes
Biotech Slump and Semiconductor Gains Shift Market Sentiment
A sharp 19% decline in Syndax Pharmaceuticals shares dominated after-hours trading Monday after the company reported that its experimental idiopathic pulmonary fibrosis treatment failed to meet primary endpoints in a Phase 2 trial. The biotechnology firm's setback stood in contrast to positive momentum across the semiconductor equipment sector.
Navitas Semiconductor also captured investor attention following the launch of a specialized power-delivery board tailored for Nvidia infrastructure. Shares of the company rose 4% to $10.39, reflecting market optimism regarding the hardware ecosystem supporting artificial intelligence development.
Comments (0)
No comments yet. Be the first!